Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial infections, especially in intensive care units (ICUs) and immunocompromised patients with central venous catheters. A. baumannii has developed a broad spectrum of antimicrobial resistance, associated with a higher mortality rate among infected patients compared with other non-baumannii species. In terms of clinical impact, resistant strains are associated with increases in both in-hospital length of stay and mortality. A. baumannii can cause a variety of infections; most involve the respiratory tract, especially ventilator-associated pneumonia, but bacteremia and skin wound infections have also been reported, the latter of which has been prominently observed in the context of war-related trauma. Cases of meningitis associated with A. baumannii have been documented. The most common risk factor for the acquisition of MDR A baumannii is previous antibiotic use, following by mechanical ventilation, length of ICU/hospital stay, severity of illness, and use of medical devices. Current efforts focus on addressing all the antimicrobial resistance mechanisms described in A. baumannii, with the objective of identifying the most promising therapeutic scheme. Bacteriophage- and artilysin-based therapeutic approaches have been described as effective, but further research into their clinical use is required
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“baumannii strain is characterized, as many other Gram-negative bacteria, by having a N-acylhomoserine lactone (AHL)-mediated quorum-sensing regulatory mechanism, which is known to be involved in biofilm formation [71], host-cell gene expression modification [72] and non-ribosomal peptide synthase (NRPS) encoding, whic…”
BackgroundAcinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
TimeTree: A Resource for Timelines, Timetrees, and Divergence Times
Kumar, S., Stecher, G., Suleski, M., & Hedges, S. B. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx116 · Cited by 2,721
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404 · cited 2×
“They confirmed a significant increase in MDR ABC isolates (14% in 1995 to 26% in 2004) [14,15].”
BackgroundColistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., & Actis, L. A. (2003) · Microbiology · doi:10.1099/mic.0.26541-0 · Cited by 599
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp
Coyne, S., Courvalin, P., & Périchon, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-10 · Cited by 505
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Gaddy, J. A., Tomaras, A. P., & Actis, L. A. (2009) · Infection and Immunity · doi:10.1128/iai.00096-09 · Cited by 482
Seven Ways to Preserve the Miracle of Antibiotics
Bartlett, J. G., Gilbert, D. N., & Spellberg, B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit070 · Cited by 468
Acinetobacter: an old friend, but a new enemy
Towner, K. J. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.03.032 · Cited by 458
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Worldwide Dissemination of the blaOXA-23Carbapenemase Gene of Acinetobacter baumannii 1
Mugnier, P. D., Poirel, L., Naas, T., & Nordmann, P. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1601.090852 · Cited by 431
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Tetracyclines, molecular and clinical aspects
Chopra, I., Hawkey, P. M., & Hinton, M. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.3.245 · Cited by 421
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Antibiotic stewardship in the intensive care unit
Luyt, C.-E., Bréchot, N., Trouillet, J.-L., & Chastre, J. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 388
Choi, A. H. K., Slamti, L., Avci, F. Y., Pier, G. B., & Maira-Litrán, T. (2009) · Journal of Bacteriology · doi:10.1128/jb.00647-09 · Cited by 387
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P., & Périchon, B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-10 · Cited by 366
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Lin, M.-F. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i12.787 · Cited by 357
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Russo, T. A., Luke, N. R., Beanan, J. M., Olson, R., Sauberan, S. L., MacDonald, U., Schultz, L. W., Umland, T. C., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00366-10 · Cited by 324
Lee, H.-W., Koh, Y. M., Kim, J., Lee, J.-C., Lee, Y.-C., Seol, S.-Y., Cho, D.-T., & Kim, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01842.x · Cited by 323
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Cisneros, J. M., & Rodríguez-Baño, J. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00487.x · Cited by 322
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
Murray, G., Peleg, A., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398388 · Cited by 316
Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
Vallenet, D., Nordmann, P., Barbe, V., Poirel, L., Mangenot, S., Bataille, E., Dossat, C., Gas, S., Kreimeyer, A., Lenoble, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001805 · Cited by 314
Antibiotic resistance management
Read, A. F., & Woods, R. J. (2014) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eou024 · Cited by 302
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Lemos, E. V., de la Hoz, F. P., Einarson, T. R., McGhan, W. F., Quevedo, E., Castañeda, C., & Kawai, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12363 · Cited by 296
Choi, C. H., Lee, J. S., Lee, Y. C., Park, T. I., & Lee, J. C. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-216 · Cited by 279
Identification and Characterization of an Acinetobacter baumannii Biofilm-Associated Protein
Loehfelm, T. W., Luke, N. R., & Campagnari, A. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01416-07 · Cited by 279
Arroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275
The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences
Touchon, M., Cury, J., Yoon, E.-J., Krizova, L., Cerqueira, G. C., Murphy, C., Feldgarden, M., Wortman, J., Clermont, D., Lambert, T., et al. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu225 · Cited by 274
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Biofilm formation by Acinetobacter baumannii.
Vidal, R., Domínguez, M., Urrutia, H., Bello, H., González, G., García, A., & Raúl Zemelman, Z. (1996) · PubMed · Cited by 271
Emergence of NDM-1-producing Acinetobacter baumannii in China
Chen, Y., Zhou, Z., Jiang, Y., & Yu, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr082 · Cited by 271
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
Yu, Z., Qin, W., Lin, J., Fang, S., & Qiu, J. (2015) · BioMed Research International · doi:10.1155/2015/679109 · Cited by 263
Chen, H. D., & Groisman, E. A. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155751 · Cited by 250
Iron uptake mechanisms and their regulation in pathogenic bacteria
Braun, V. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00103 · Cited by 249
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
Antunes, L. C. S., Imperi, F., Carattoli, A., & Visca, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022674 · Cited by 244
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
AYDEMIR, H., AKDUMAN, D., PISKIN, N., COMERT, F., HORUZ, E., TERZI, A., KOKTURK, F., ORNEK, T., & CELEBI, G. (2013) · Epidemiology and Infection · doi:10.1017/s095026881200194x · Cited by 225
Viehman, J. A., Nguyen, M. H., & Doi, Y. (2014) · Drugs · doi:10.1007/s40265-014-0267-8 · Cited by 215
Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
Jacobs, A. C., Hood, I., Boyd, K. L., Olson, P. D., Morrison, J. M., Carson, S., Sayood, K., Iwen, P. C., Skaar, E. P., & Dunman, P. M. (2010) · Infection and Immunity · doi:10.1128/iai.00889-09 · Cited by 214
Sampson, T. R., Liu, X., Schroeder, M. R., Kraft, C. S., Burd, E. M., & Weiss, D. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-12 · Cited by 205
Jawad, A., Heritage, J. C., Snelling, A. M., Gascoyne‐Binzi, D., & Hawkey, P. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2881-2887.1996 · Cited by 202
Boll, J. M., Tucker, A. T., Klein, D. R., Beltran, A. M., Brodbelt, J. S., Davies, B. W., & Trent, M. S. (2015) · mBio · doi:10.1128/mbio.00478-15 · Cited by 200
Rumbo, C., Gato, E., López, M., Ruiz de Alegría, C., Fernández-Cuenca, F., Martínez-Martínez, L., Vila, J., Pachón, J., Cisneros, J. M., Rodríguez-Baño, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00730-13 · Cited by 193
Jeon, J., Lee, J., Lee, J., Park, K., Karim, A., Lee, C.-R., Jeong, B., & Lee, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059654 · Cited by 192
Batirel, A., Balkan, I. I., Karabay, O., Agalar, C., Akalin, S., Alici, O., Alp, E., Altay, F. A., Altin, N., Arslan, F., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2070-6 · Cited by 182
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Knapp, S., Wieland, C. W., Florquin, S., Pantophlet, R., Dijkshoorn, L., Tshimbalanga, N., Akira, S., & van der Poll, T. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-730oc · Cited by 180
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C., & Boucher, B. A. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 174
Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing
Camarena, L., Bruno, V., Euskirchen, G., Poggio, S., & Snyder, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000834 · Cited by 171
Giammanco, A., Calà, C., Fasciana, T., & Dowzicky, M. J. (2017) · mSphere · doi:10.1128/msphere.00310-16 · Cited by 169
Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate
Kwon, S.-O., Gho, Y. S., Lee, J. C., & Kim, S. I. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01669.x · Cited by 167
Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity
Choi, C. H., Hyun, S. H., Lee, J. Y., Lee, J. S., Lee, Y. S., Kim, S. A., Chae, J.-P., Yoo, S. M., & Lee, J. C. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01041.x · Cited by 166
Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., Xu, M., Guo, X., Hu, F., & He, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02659 · Cited by 166
Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
Lob, S. H., Hoban, D. J., Sahm, D. F., & Badal, R. E. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.01.015 · Cited by 163 · cited 3×
“In particular, MDR rates reach about 70% in Latin America and the Middle East [35].”
BackgroundKim, S. W., Choi, C. H., Moon, D. C., Jin, J. S., Lee, J. H., Shin, J.-H., Kim, J. M., Lee, Y. C., Seol, S. Y., Cho, D. T., et al. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01820.x · Cited by 163
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Giannouli, M., Antunes, L. C. S., Marchetti, V., Triassi, M., Visca, P., & Zarrilli, R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-282 · Cited by 160
Chusri, S., Chongsuvivatwong, V., Rivera, J. I., Silpapojakul, K., Singkhamanan, K., McNeil, E. B., & Doi, Y. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02992-14 · Cited by 156
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Hornsey, M., Ellington, M. J., Doumith, M., Thomas, C. P., Gordon, N. C., Wareham, D. W., Quinn, J. P., Lolans, K., Livermore, D. M., & Woodford, N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq218 · Cited by 146
Adams‐Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., & Doi, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-08 · Cited by 145
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Sheng, W., Liao, C., Lauderdale, T.-L. Y., Ko, W., Chen, Y.-S., Liu, J.-W., Lau, Y.-J., Wang, L.-S., Liu, K.-S., Tsai, T.-Y., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.02.2254 · Cited by 136
Poirel, L., Girlich, D., Naas, T., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.447-453.2001 · Cited by 129
Principe, L., D’Arezzo, S., Capone, A., Petrosillo, N., & Visca, P. (2009) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-8-18 · Cited by 128
Yang, Y., Bhachech, N., & Bush, K. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.75 · Cited by 123
Edwards, J. R., Turner, P. J., Wannop, C., et al. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.215 · Cited by 117
Rodríguez-Hernández, M. J., Pachón, J., Pichardo, C., Cuberos, L., Ibáñez-Martínez, J., García-Curiel, A., Caballero, F. J., Moreno, I., & Me, J.-M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.493 · Cited by 117
Luke, N. R., Sauberan, S. L., Russo, T. A., Beanan, J. M., Olson, R., Loehfelm, T. W., Cox, A. D., St. Michael, F., Vinogradov, E. V., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00016-10 · Cited by 114 · cited 1×
“baumannii, is implicated in lipopolysaccharide (LPS) biosynthesis [41], a component of Gram-negative bacteria that is released after lysis or multiplication [42].”
BackgroundSader, H. S., Jones, R. N., Dowzicky, M. J., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.002 · Cited by 114
Pachón-Ibáñez, M. E., Docobo-Pérez, F., López-Rojas, R., Domínguez-Herrera, J., Me, J.-M., García-Curiel, A., Pichardo, C., Jiménez, L., & Pachón, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00367-09 · Cited by 114
Erridge, C., Moncayo-Nieto, O. L., Morgan, R., Young, M., & Poxton, I. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46823-0 · Cited by 112
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 107
Aminoglycoside Resistance by ArmA-mediated Ribosomal 16S Methylation in Human Bacterial Pathogens
Liou, G. F., Yoshizawa, S., Courvalin, P. M., & Galimand, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.038 · Cited by 104
Rolain, J., Diene, S. M., Kempf, M., Gimenez, G., Robert, C., & Raoult, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-12 · Cited by 104
Treatment of multidrug resistant Acinetobacter
Murray, C. K., & Hospenthal, D. R. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000185985.64759.41 · Cited by 103
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl130 · Cited by 102
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
Krizova, L., Poirel, L., Nordmann, P., & Nemec, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt275 · Cited by 100
Houang, E. T. S., Chu, Y.-W., Lo, W. U., Chu, K. Y., & Cheng, A. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1382-1390.2003 · Cited by 99
Wood, G. C., Hanes, S. D., Boucher, B. A., Croce, M. A., & Fabian, T. C. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1811-2 · Cited by 93
Wang, L., Liu, X., Huang, J., Zhu, D., Li, J., & Zhang, J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-109 · Cited by 92
Cho, Y. J., Moon, D. C., Jin, J. S., Choi, C. H., Lee, Y. C., & Lee, J. C. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.02.010 · Cited by 91
Lopes, B. S., & Amyes, S. G. B. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.044156-0 · Cited by 85
Akers, K. S., Chaney, C., Barsoumian, A. E., Beckius, M. L., Zera, W. C., Yu, X., Guymon, C. H., Keen, E. F., ROBINSON, B. J., Mende, K., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02006-09 · Cited by 84
Holloway, K. P., Rouphael, N., Wells, J. B., King, M. D., & Blumberg, H. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h353 · Cited by 84
March, C., Regueiro, V., Llobet, E., Moranta, D., Morey, P., Garmendia, J., & Bengoechea, J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010033 · Cited by 76
Jeon, J., Ryu, C., Lee, J.-Y., Park, J., Yong, D., & Lee, K. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00526-16 · Cited by 74
Figueiredo, S., Poirel, L., Papa, A., Koulourida, V., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00292-09 · Cited by 72
Bae, S., Kim, M., Park, S., Kim, H. S., Sung, H., Kim, M., Kim, S., Lee, S., Choi, S., Woo, J. H., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00839-16 · Cited by 72
Urban, C. M., Go, E., Mariano, N., & Rahal, J. J. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07357.x · Cited by 71
Peck, K. R., Kim, M. J., Choi, J. Y., Kim, H. S., Kang, C., Cho, Y. K., Park, D. W., Lee, H. J., Lee, M. S., & Ko, K. S. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.036939-0 · Cited by 70
Fan, B., Guan, J., Wang, X., & Cong, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157757 · Cited by 69
Munoz-Price, L. S., Zembower, T., Penugonda, S., Schreckenberger, P. C., Lavin, M. A., Welbel, S. F., Vais, D., Baig, M. W., Mohapatra, S., Quinn, J. P., et al. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/656247 · Cited by 64
Risk factors for nephrotoxicity onset associated with polymyxin B therapy
Dubrovskaya, Y., Prasad, N., Lee, Y., Esaian, D., Figueroa, D. A., & Tam, V. H. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv014 · Cited by 63
Convergence of hormones and autoinducers at the host/pathogen interface
Rumbaugh, K. P. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0694-9 · Cited by 62
Girija, A. S. S., Jayaseelan, V. P., & Arumugam, P. (2018) · British Journal of Biomedical Science · doi:10.1080/09674845.2018.1492207 · Cited by 60
Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter Baumannii
Esterly, J. S., Richardson, C. L., Eltoukhy, N., Qi, C., & Scheetz, M. H. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p084 · Cited by 51
Effect of iron-limiting conditions on growth of clinical isolates of Acinetobacter baumannii
Actis, L. A., Tolmasky, M. E., Crosa, L. M., & Crosa, J. H. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.10.2812-2815.1993 · Cited by 49
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Bergen, P. J., Bulman, Z. P., Landersdorfer, C. B., Smith, N. M., Lenhard, J. R., Bulitta, J. B., Nation, R. L., Li, J., & Tsuji, B. T. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0093-7 · Cited by 49
2-Hydroxylation of Acinetobacter baumannii Lipid A Contributes to Virulence
Bartholomew, T. L., Kidd, T. J., Sá‐Pessoa, J., Conde-Álvarez, R., & Bengoechea, J. A. (2019) · Infection and Immunity · doi:10.1128/iai.00066-19 · Cited by 47
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Rao, G. G., Ly, N. S., Bulitta, J. B., Soon, R. L., Roman, M. D. S., Holden, P. N., Landersdorfer, C. B., Nation, R. L., Li, J., Forrest, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw293 · Cited by 43
Kim, S. A., Yoo, S. M., Hyun, S. H., Choi, C. H., Yang, S. Y., Kim, H., Jang, B. C., Suh, S. I., & Lee, J. C. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00446.x · Cited by 33
Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis
Tütüncü, E. E., Kuşçu, F., Gürbüz, Y., Öztürk, B., Solay, A. H., & Şencan, İ. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.07.022 · Cited by 25
Cirioni, O., Simonetti, O., Pierpaoli, E., Barucca, A., Ghiselli, R., Orlando, F., Pelloni, M., Trombettoni, M. M. C., Guerrieri, M., Offidani, A., et al. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.010 · Cited by 25
Blossom, D. B., & Srinivasan, A. (2008) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3181635def · Cited by 16
Isolation of Lipid Cell Envelope Components from Acinetobacter baumannii
Powers, M. J., Herrera, C. M., Tucker, A. T., Davies, B. W., & Trent, M. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9118-1_22 · Cited by 16
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Kyriakidis, I., Vasileiou, E., Pana, Z. D., & Tragiannidis, A. (2021) · Pathogens · doi:10.3390/pathogens10030373 · Cited by 678
Nguyen, M., & Joshi, S. G. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15130 · Cited by 259
Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?
Kariuki, S., Kering, K., Wairimu, C., Onsare, R., & Mbae, C. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s342753 · Cited by 245
Rizk, S. S., Elwakil, W. H., & Attia, A. S. (2021) · Antibiotics · doi:10.3390/antibiotics10070764 · Cited by 23
Metadata
- Authors
- Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., Moncaleano Guzmán, V., Juárez Bañuelos, J. E., Marcos Felix, J., González Barrios, J. A., & Barrientos Fortes, T.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2020-04-23
- Volume
- 9
- Issue
- 4
- Pages
- 205
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W3018857444
- Cited by
- 296
- References
- 134
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.